Sprint Precision Technologies
688605
Jiangsu Jingxue Insulation Technology
301010
Global Infotech
300465
Hydsoft Technology
301316
SGSG Science&Technology
300561
CN Stock MarketDetailed Quotes
600380 Joincare Pharmaceutical Group Industry
- 11.72
- +0.13+1.12%
Not Open Dec 12 15:00 CST
21.97BMarket Cap14.93P/E (TTM)
11.75High11.55Low162.05KlotVolume11.60Open11.59Pre Close189.44MTurnover0.87%Turnover Ratio15.22P/E (Static)1.87BShares13.0752wk High1.52P/B21.97BFloat Cap9.4052wk Low12.75Limit Up1.87BShs Float23.84Historical High10.43Limit Down1.73%Amplitude0.83Historical Low0.18Dividend TTM11.69Avg Price71.27KlotAsk1.54%Div YieldTTM100Lot Size88.49KlotBid
Joincare Pharmaceutical Group Industry Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -5.95%11.9B | -5.56%8.23B | -4.81%4.34B | -2.90%16.65B | -2.77%12.65B | 1.81%8.72B | -2.11%4.56B | 7.79%17.14B | 9.04%13.01B | 9.31%8.56B |
| Operating revenue | -5.95%11.9B | -5.56%8.23B | -4.81%4.34B | -2.90%16.65B | -2.77%12.65B | 1.81%8.72B | -2.11%4.56B | 7.79%17.14B | 9.04%13.01B | 9.31%8.56B |
| Other operating revenue | ---- | -8.63%61.17M | ---- | -4.15%124.63M | ---- | -8.16%66.95M | ---- | -17.22%130.02M | ---- | 40.58%72.9M |
| Total operating cost | -8.71%9.12B | -8.83%6.25B | -7.50%3.3B | -4.80%13.12B | -3.43%9.99B | 1.25%6.85B | -2.38%3.56B | 4.67%13.78B | 6.36%10.35B | 7.22%6.77B |
| Operating cost | -9.15%4.39B | -7.71%3.02B | -7.29%1.59B | 0.74%6.3B | 5.36%4.84B | 7.17%3.27B | 6.36%1.71B | 9.38%6.25B | 9.24%4.59B | 11.35%3.05B |
| Operating tax surcharges | -8.46%137.57M | -8.48%94M | -14.46%46.72M | 1.73%203.21M | 1.49%150.28M | 8.89%102.71M | 4.62%54.61M | 9.26%199.75M | 6.84%148.07M | 4.40%94.32M |
| Operating expense | -13.91%2.95B | -12.61%2.1B | -10.07%1.1B | -10.43%4.43B | -11.95%3.43B | -4.51%2.4B | -13.64%1.22B | -1.51%4.95B | 1.91%3.89B | 0.50%2.51B |
| Administration expense | 4.22%708.73M | 2.34%445.02M | 24.10%259.69M | -6.25%930.48M | -16.37%680.01M | -17.92%434.87M | -17.24%209.26M | 5.67%992.48M | 24.91%813.14M | 33.15%529.83M |
| Financial expense | 66.30%-105.97M | -0.93%-123.73M | -364.30%-73.64M | -14.87%-404.84M | 4.83%-314.42M | 5.99%-122.59M | 48.03%-15.86M | -279.41%-352.45M | -662.95%-330.37M | -212.51%-130.4M |
| -Interest expense (Financial expense) | -10.76%94.97M | 3.42%72.46M | 2.11%33.73M | 5.55%146.73M | 11.04%106.42M | 14.89%70.06M | 10.66%33.04M | 53.99%139.02M | 30.26%95.84M | 57.53%60.98M |
| -Interest Income (Financial expense) | 34.09%-245.99M | -37.88%-187.44M | -50.62%-102.75M | -34.59%-532.25M | -25.96%-373.19M | -15.70%-135.95M | 0.37%-68.22M | -106.02%-395.48M | -165.03%-296.27M | -50.58%-117.5M |
| Research and development | -14.46%1.04B | -6.59%714.73M | -1.07%377.1M | -4.61%1.66B | -1.70%1.21B | 8.16%765.17M | 8.49%381.17M | 24.69%1.74B | 28.51%1.23B | 13.56%707.43M |
| Credit Impairment Loss | 95.51%-797.21K | 82.56%-3.87M | 57.41%-6.58M | -308.52%-16.85M | -86.54%-17.74M | -691.65%-22.21M | -7,198.75%-15.46M | 48.61%-4.12M | 9.87%-9.51M | 70.42%-2.81M |
| Asset Impairment Loss | -4.84%-113.69M | -172.39%-82.19M | -321.87%-4.08M | -119.01%-312.37M | 23.72%-108.44M | -8.40%-30.17M | 134.61%1.84M | -126.57%-142.63M | -297.11%-142.16M | 3.61%-27.83M |
| Other net revenue | 49.64%55.24M | -99.92%72.53K | -11.15%46.84M | -113.32%-16.27M | 179.40%36.91M | 319.58%90.74M | 83.67%52.72M | -50.91%122.12M | -123.21%-46.49M | -88.69%21.63M |
| Fair value change income | 87.53%-5.74M | 50.21%-19.58M | 104.23%1.16M | 66.67%-25.42M | 47.12%-46M | 58.82%-39.31M | 49.26%-27.48M | -224.44%-76.26M | -382.88%-86.99M | -386.58%-95.48M |
| Invest income | -11.81%51.65M | -37.83%35.35M | -48.47%20.42M | 41.99%79.47M | 21.05%58.57M | 11.45%56.85M | 35.81%39.63M | -22.13%55.97M | -30.14%48.39M | 8.98%51.01M |
| -Including: Investment income associates | -40.61%34.37M | -46.91%23.8M | 58.64%18.2M | 3.14%72.79M | 10.30%57.87M | 8.77%44.82M | -24.56%11.47M | 586.48%70.58M | 345.05%52.47M | 322.63%41.21M |
| Asset deal income | -84.76%-370.4K | 77.67%-76.44K | --306.57K | 75.91%-169.9K | -117.87%-200.48K | 32.94%-342.36K | ---- | -102.93%-705.36K | -93.89%1.12M | -102.85%-510.52K |
| Other revenue | -17.61%124.18M | -44.06%70.44M | -34.28%35.61M | -10.63%259.06M | 5.65%150.73M | 29.50%125.93M | -8.37%54.19M | 17.19%289.87M | -19.41%142.66M | -26.03%97.24M |
| Operating profit | 5.06%2.83B | 1.48%1.99B | 4.00%1.09B | 0.77%3.51B | 2.98%2.7B | 7.66%1.96B | 1.22%1.05B | 16.66%3.48B | 8.83%2.62B | 6.10%1.82B |
| Add:Non operating Income | 9.80%6.92M | 181.15%4.94M | 114.44%1.88M | -3.03%7.98M | 26.18%6.3M | -60.69%1.76M | -62.25%876.58K | -4.77%8.23M | -11.78%5M | -3.67%4.47M |
| Less:Non operating expense | -15.89%19.99M | 33.38%9.83M | 58.92%5.88M | 52.81%48.99M | 72.99%23.77M | 9.32%7.37M | 77.44%3.7M | -18.58%32.06M | -28.15%13.74M | 11.62%6.74M |
| Total profit | 5.25%2.82B | 1.53%1.98B | 3.90%1.09B | 0.27%3.47B | 2.66%2.68B | 7.48%1.95B | 0.93%1.05B | 17.06%3.46B | 9.08%2.61B | 6.05%1.82B |
| Less:Income tax cost | -11.11%385.62M | -11.97%285.81M | -3.46%161.42M | 9.39%614.54M | 6.33%433.82M | 19.72%324.66M | -3.77%167.21M | 65.49%561.8M | 28.92%408.01M | 10.88%271.18M |
| Net profit | 8.42%2.43B | 4.22%1.7B | 5.30%925.1M | -1.50%2.85B | 1.98%2.24B | 5.33%1.63B | 1.87%878.52M | 10.77%2.89B | 6.06%2.2B | 5.25%1.55B |
| Net profit from continuing operation | 8.42%2.43B | 4.22%1.7B | 5.30%925.1M | -1.50%2.85B | 1.98%2.24B | 5.33%1.63B | 1.87%878.52M | 10.77%2.89B | 6.06%2.2B | 5.25%1.55B |
| Less:Minority Profit | 13.86%1.32B | 13.26%919.79M | 16.72%485.3M | 1.20%1.41B | 8.04%1.16B | 9.17%812.14M | 3.47%415.77M | 8.35%1.39B | 0.73%1.07B | -4.72%743.91M |
| Net profit of parent company owners | 2.58%1.11B | -4.78%776.42M | -4.96%439.8M | -3.99%1.44B | -3.81%1.08B | 1.77%815.43M | 0.48%462.75M | 13.12%1.5B | 11.69%1.13B | 16.57%801.27M |
| Add:Adjusted items effecting net profit of parent company owners | ---- | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | ---- | ---- |
| Earning per share | ||||||||||
| Basic earning per share | 4.63%0.5945 | -2.49%0.4158 | -1.96%0.2357 | -4.46%0.758 | -5.03%0.5682 | 0.68%0.4264 | -0.29%0.2404 | 15.59%0.7934 | 16.08%0.5983 | 20.52%0.4235 |
| Diluted earning per share | 4.96%0.5944 | -2.28%0.4154 | -1.79%0.2355 | -4.51%0.7565 | -5.16%0.5663 | 0.45%0.4251 | -0.50%0.2398 | 15.51%0.7922 | 16.12%0.5971 | 20.78%0.4232 |
| Other composite income | -282.58%-86.69M | -196.73%-29.1M | 73.05%-22.55M | -148.06%-35.86M | -128.18%-22.66M | 220.02%30.08M | 21.69%-83.67M | 141.99%74.61M | 145.41%80.41M | 84.44%-25.06M |
| Other composite income of parent company owners | -6,002.98%-59.37M | -175.93%-23.68M | 78.78%-10.03M | -2,078.08%-14.88M | -96.86%1.01M | 172.52%31.18M | 49.09%-47.29M | 99.38%-683.07K | 135.33%31.98M | 46.29%-43M |
| Other composite income of minority owners | -15.44%-27.32M | -392.17%-5.42M | 65.61%-12.51M | -127.87%-20.98M | -148.86%-23.66M | -106.14%-1.1M | -160.61%-36.39M | 212.75%75.29M | 155.96%48.43M | 122.13%17.94M |
| Add:Adjusted items effecting composite income | ---- | ---- | ---- | ---- | ---- | ---- | ---0.01 | ---- | ---- | ---- |
| Total composite income | 5.62%2.35B | 0.57%1.67B | 13.55%902.55M | -5.18%2.82B | -2.61%2.22B | 9.05%1.66B | 5.21%794.85M | 21.92%2.97B | 20.18%2.28B | 16.31%1.52B |
| Total composite income of parent company owners | -2.99%1.05B | -11.09%752.75M | 3.44%429.77M | -4.94%1.43B | -6.38%1.08B | 11.65%846.62M | 13.00%415.46M | 23.37%1.5B | 26.18%1.16B | 24.86%758.27M |
| Total composite income of minority owners | 13.83%1.29B | 12.74%914.37M | 24.62%472.79M | -5.42%1.39B | 1.28%1.14B | 6.46%811.03M | -2.18%379.39M | 20.47%1.47B | 14.56%1.12B | 8.88%761.85M |
| Add:Adjusted items effecting total composite income | ---- | ---- | ---- | ---- | ---- | --0.01 | ---- | --0.01 | ---- | ---- |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- | -- | Grant Thornton Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
